CVE-2020-12016
Official description Straight from the sourceThe vendor's or NVD's own wording, published unedited. Authoritative, but often terse — it says what broke, rarely what to do.
NVD · uneditedBaxter ExactaMix EM 2400 & EM 1200, Versions ExactaMix EM2400 Versions 1.10, 1.11, 1.13, 1.14, ExactaMix EM1200 Versions 1.1, 1.2, 1.4, 1.5, Baxter ExactaMix EM 2400 Versions 1.10, 1.11, 1.13, 1.14 and ExactaMix EM1200 Versions 1.1, 1.2, 1.4 and 1.5 have hard-coded administrative account credentials for the ExactaMix operating system. Successful exploitation of this vulnerability may allow an attacker who has gained unauthorized access to system resources, including access to execute software or to view/update files, directories, or system configuration. This could allow an attacker with network access to view sensitive data including PHI.
Technical summary Written by usOur analysis, written from the advisory, the CVSS vector and the affected-version data. It adds context the advisory leaves out, and never invents facts that are not in the source.
dbcve analysis · high confidenceThe Baxter ExactaMix EM 2400 and EM 1200 intravenous compounding systems contain hard-coded administrative account credentials embedded in the operating system. An attacker with network access can use these credentials to gain unauthorized access, execute arbitrary software, and view sensitive files including Protected Health Information (PHI).
Verify against the referenced sources before acting — the references below are authoritative for this CVE, this summary is not.
Affected products & versions What the vendor confirmedThe version ranges the vendor confirmed as vulnerable. If your version sits inside a range here, treat yourself as exposed until you have upgraded.
NVD · CPE data= 1.10= 1.11= 1.13= 1.14= 1.1= 1.2= 1.4= 1.5CVSS breakdown How the score is builtThe industry scoring standard. It rates how the flaw is reached, what it takes to exploit, and what an attacker gains — the score is derived from those, not the other way round.
From the vector- Attack vector
- Network
- Complexity
- Low
- Privileges
- None
- User interaction
- None
- Scope
- Unchanged
- Confidentiality
- High
- Integrity
- High
- Availability
- High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Am I affected? How to checkSteps we derive from the advisory and the affected-version data, so you can decide whether this CVE reaches your setup. They are a guide, not a scan — your own configuration is the authority.
dbcve checksWork through these to decide whether this CVE applies to you.
-
Identify the Baxter ExactaMix device modelLocate the device nameplate or system information screen on the intravenous compounding system. Look for ExactaMix EM 2400 or EM 1200 labeling.Affected if The device is an EM 2400 or EM 1200 model
-
Check the installed firmware versionAccess the device system settings or maintenance menu and navigate to the firmware version information screen. Record the version number displayed.Affected if The firmware version matches 1.10, 1.11, 1.13, or 1.14 for EM2400 OR 1.1, 1.2, 1.4, or 1.5 for EM1200
-
Verify if default administrative credentials are still activeAttempt to log into the device web interface or console using known default administrative account credentials, or review authentication configuration files if accessible through maintenance mode.Affected if The default hardcoded administrative credentials grant access to the device
-
Assess network accessibility to the deviceScan the network for the device IP address and test whether ports 80, 443, or other management ports are exposed beyond the local segment. Check if the device is accessible from untrusted network zones.Affected if The device management interface is reachable from network segments outside the clinical network
A user is affected if they have an EM 2400 or EM 1200 device running one of the listed firmware versions with the hardcoded credentials still active and accessible over the network.
Generated from the published advisory. Verify against your own configuration.
Remediation Closing itWhat it takes to close this. Where a vendor fix exists we point at it; where none exists we say so plainly, and can build one. Effort estimates are scoped from the advisory, not from your codebase.
From vendor dataImmediately change or remove the hardcoded credentials, implement network segmentation to restrict access to the device, and coordinate with Baxter for formal patches and vendor guidance on secure credential management.
- Consultation12.0 h
- Implementation20.0 h
- Testing12.0 h
- Review / QA8.0 h
An estimate, not a bill — we confirm scope with you before any work starts. Need it this week? Rush from $14,784.
Scan for this in your stack
Free · runs locallyCheck whether your project pulls in CVE-2020-12016 — or any other known-vulnerable package — straight from your lock files. Free and open source; it runs locally and uploads nothing.
References Go to the primary sourcePrimary sources — vendor advisories, patches and trackers. Where our summary and a reference disagree, the reference wins.
Primary sourcesPractitioner notes
ContributedPeer-ranked notes from engineers who’ve handled CVE-2020-12016 in production — separate from our analysis above.
The advisory tells you what broke. It rarely tells you what actually worked. If you’ve dealt with this one, that detail is what the next engineer is searching for.
- The version that genuinely resolved it — not the one the vendor claimed
- A config change or rule that shut the vector down
- A gotcha in the upgrade path that cost you an afternoon
No notes yet
Be the first to add a field note for this CVE — a mitigation you’ve verified, a version caveat, or a link to a working fix. Sign in above to contribute.
A place for practitioners to share what actually worked: a mitigation you’ve tested, a configuration change, a version- or environment-specific caveat, or a link to a verified patch. The most useful notes rise to the top as peers upvote them, so the signal stays high.
- Verified mitigations, workarounds, and config changes
- Version or environment caveats, and links to real fixes
- No weaponised exploit code, or anything meant to cause harm
- No spam, self-promotion, credentials, or personal data